Sec Form 13G Filing - Radoff Bradley Louis filing for QUMU CORP COM (QUMU) - 2020-03-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)

(Amendment No.  )*

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

CUSIP NO. 749063103

2

CUSIP NO. 749063103

3

CUSIP NO. 749063103

4

CUSIP NO. 749063103

5

CUSIP NO. 749063103

6

CUSIP NO. 749063103

7

CUSIP NO. 749063103

Item 1(a).                  Name of Issuer:

Qumu Corporation, a Minnesota corporation (the “Issuer”)

Item 1(b).                  Address of the Issuer’s Principal Executive Offices:

510 1st Avenue North
Suite 305
Minneapolis, MN 55403

Item 2(a).                  Name of Person Filing:

This statement is filed by BLR Partners LP, a Texas limited partnership (“BLR Partners”), BLRPart, LP, a Texas limited partnership (“BLRPart GP”), BLRGP Inc., a Texas S corporation (“BLRGP”), Fondren Management, LP, a Texas limited partnership (“Fondren Management”), FMLP Inc., a Texas S corporation (“FMLP”) and Bradley L. Radoff. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.”

BLRPart GP serves as the general partner of BLR Partners. BLRGP serves as the general partner of BLRPart GP. Fondren Management serves as the investment manager of BLR Partners. FMLP serves as the general partner of Fondren Management. Mr. Radoff serves as the sole shareholder and sole director of each of BLRGP and FMLP. By virtue of these relationships, BLRPart GP, BLRGP, Fondren Management, FMLP and Mr. Radoff may be deemed to beneficially own the Shares (as defined below) owned directly by BLR Partners.

Item 2(b).                  Address of Principal Business Office or, if None, Residence:

The address of the principal office of each of the Reporting Persons is 1177 West Loop South, Suite 1625, Houston, Texas  77027.

Item 2(c).                   Citizenship:

BLR Partners, BLRPart GP, BLRGP, Fondren Management and FMLP are organized under the laws of the State of Texas.  Mr. Radoff is a citizen of the United States of America.

Item 2(d).                  Title of Class of Securities:

Common Stock, par value $0.01 (“Shares”)

Item 2(e).                   CUSIP Number:

749063103

Item 3.                                 If this statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

8

CUSIP NO. 749063103

Item 4.                                 Ownership.

Item 4(a).                  Amount Beneficially Owned:

As of the close of business on March 2, 2020:

(i)                                     BLR Partners directly owned 1,020,000 Shares; and

(ii)                                  Each of BLRPart GP, as the general partner of BLR Partners, BLRGP, as the general partner of BLRPart GP, Fondren Management, as the investment manager of BLR Partners, FMLP, as the general partner of Fondren Management, and Mr. Radoff, as the sole shareholder and sole director of each of BLRGP and FMLP, may be deemed the beneficial owner of the 1,020,000 Shares owned by BLR Partners.

The filing of this Schedule 13G shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any of the Shares reported herein that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the Shares reported herein that are not directly owned by such Reporting Person.

Item 4(b).                  Percent of Class:

The following percentages are based on 13,553,468 Shares outstanding as of February 9, 2020, which is the total number of Shares outstanding as represented in Section 3.5(a)(i) of the Agreement and Plan of Merger and Reorganization, dated February 11, 2020, by and among Synacor, Inc., Quantum Merger Sub I, Inc. and the Issuer, attached as Exhibit 2.1 to the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 11, 2020.

As of the close of business on March 2, 2020, each of BLR Partners, BLRPart GP, BLRGP, Fondren Management, FMLP and Mr. Radoff may be deemed to beneficially own approximately 7.5% of the outstanding Shares.

Item 4(c).                   Number of shares as to which such person has:

Item 5.                                 Ownership of Five Percent or Less of a Class.

Not applicable.

9

CUSIP NO. 749063103

Item 6.                                 Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.                                 Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8.                                 Identification and Classification of Members of the Group.

See Exhibit 99.1.

Item 9.                                 Notice of Dissolution of Group

Not applicable.

Item 10.                          Certification

By signing below each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

10

CUSIP NO. 749063103

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

11